ARTICLE
25 September 2013

Ajanta Pharma Ltd. Succeeded In Revoking Two Composition Patents Of Allergan Inc.

SO
S&A Law Offices

Contributor

S&A Law Offices is a full-service law firm comprising experienced, well-recognized and accomplished professionals. S&A Law Offices aims to provide its clients (both domestic and international) with top-quality counsel and legal insights, which combines the Firm's innovative approach with comprehensive expertise across industries and a broad spectrum of modalities. Being a full-service law firm, we take pride in having the capability of providing impeccable legal solutions across various practice areas and industries and makes an endeavor to provide a 360 degree legal solution. With registered office at Gurugram and other strategically located offices in New Delhi, Mumbai, and Bengaluru, along with associate offices across India, S&A is fully equipped to provide legal services on a pan-India basis.
Ajanta Pharma Ltd. filed a revocation application against Allergan's patents viz. IN 212695 and IN 219504 granted by the Kolkata Patent Office in December 2007 and May 2008 respectively.
India Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

Ajanta Pharma Ltd. filed a revocation application against Allergan's patents viz. IN 212695 and IN 219504 granted by the Kolkata Patent Office in December 2007 and May 2008 respectively. Both the patents were on drugs to cure Ocular Hypertension (Glaucoma) and were applied for a revocation on the grounds of obviousness, not an invention, not patentable, insufficiency and non-compliance of Section 8 of the Indian Patents (Amendment) Act, 2005.

It was held by the IPAB that the application was not time barred. The right to revoke patent any time after the grant of patent under Section 64 of the Act cannot be extinguished by applying limitation of three years under Article 137 of the Limitation Act.

The IPAB rightly revoked both these patents on grounds of Obviousness and Breach of Section 8 of Indian Patents (Amendment) Act, 2005, as put forward by Ajanta Pharma Ltd.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More